Shahin Lockman Selected Research

Zidovudine (Retrovir)

1/2018	Emulating a target trial of antiretroviral therapy regimens started before conception and risk of adverse birth outcomes.
10/2017	Comparative Safety of Antiretroviral Treatment Regimens in Pregnancy.
1/2012	High prevalence of hypertension and placental insufficiency, but no in utero HIV transmission, among women on HAART with stillbirths in Botswana.
4/2011	Increased risk of severe infant anemia after exposure to maternal HAART, Botswana.
2/2011	Effects of in utero antiretroviral exposure on longitudinal growth of HIV-exposed uninfected infants in Botswana.
8/2008	Hematologic and hepatic toxicities associated with antenatal and postnatal exposure to maternal highly active antiretroviral therapy among infants.
8/2006	Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study.
6/2006	Maternal single-dose nevirapine versus placebo as part of an antiretroviral strategy to prevent mother-to-child HIV transmission in Botswana.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shahin Lockman Research Topics

Disease

12	HIV Infections (HIV Infection) 01/2021 - 06/2006
10	Infections 01/2020 - 04/2010
8	Pregnancy Complications 01/2022 - 12/2012
8	Acquired Immunodeficiency Syndrome (AIDS) 10/2019 - 06/2006
6	Stillbirth 01/2022 - 01/2012
4	Perinatal Death 01/2022 - 10/2017
4	Neutropenia 01/2018 - 08/2008
3	Anemia 04/2022 - 04/2011
3	Premature Birth (Birth, Premature) 04/2022 - 10/2017
3	Birth Weight (Birth Weights) 01/2022 - 02/2011
3	Hypertension (High Blood Pressure) 01/2020 - 01/2012
3	Neoplasms (Cancer) 01/2019 - 01/2016
2	Neural Tube Defects (Exencephaly) 01/2021 - 01/2019
2	Weight Gain 01/2021 - 12/2020
2	Viremia 01/2021 - 10/2019
2	Congenital Abnormalities (Deformity) 01/2019 - 04/2016
2	Inflammation (Inflammations) 05/2018 - 07/2012
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 06/2014
2	Disease Progression 11/2014 - 07/2013
2	Malaria 02/2012 - 01/2012
1	Hodgkin Disease (Hodgkin's Disease) 01/2022
1	Vaginal Discharge 08/2021
1	Diarrhea 01/2020
1	Pneumonia (Pneumonitis) 01/2020
1	Cytomegalovirus Infections (Inclusion Disease) 01/2020
1	Tetanus 01/2020
1	Syphilis 01/2019
1	Anencephaly (Aprosencephaly) 01/2019
1	Meningomyelocele (Myelomeningocele) 01/2019
1	Encephalocele (Encephalocele, Frontal) 01/2019
1	Renal Insufficiency (Renal Failure) 05/2014
1	Maternal Death 07/2013
1	Pre-Eclampsia (Preeclampsia) 04/2013
1	Erythema 02/2013
1	Edema (Dropsy) 02/2013
1	Liver Diseases (Liver Disease) 01/2013
1	Myocardial Infarction 07/2012
1	Exanthema (Rash) 04/2012
1	Hepatitis 04/2012

Drug/Important Bio-Agent (IBA)

9	Nevirapine (Viramune)FDA Link 10/2019 - 06/2006
8	Zidovudine (Retrovir)FDA LinkGeneric 01/2018 - 06/2006
7	efavirenz (Sustiva)FDA Link 01/2021 - 04/2016
7	RNA (Ribonucleic Acid)IBA 01/2021 - 04/2010
7	Emtricitabine (Emtriva)FDA Link 01/2021 - 06/2015
7	Tenofovir (Viread)FDA Link 10/2019 - 05/2014
6	dolutegravirIBA 01/2021 - 01/2018
6	Ritonavir (Norvir)FDA Link 10/2017 - 01/2012
5	Lopinavir FDA Link 10/2017 - 01/2012
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 05/2018
4	VaccinesIBA 01/2020 - 10/2011
4	octaneIBA 10/2019 - 01/2012
4	Pharmaceutical PreparationsIBA 10/2019 - 08/2005
4	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2018 - 01/2013
3	Lamivudine (Epivir)FDA Link 01/2018 - 06/2015
3	RacivirIBA 01/2018 - 04/2016
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2016 - 07/2013
2	IronIBA 01/2022 - 04/2011
2	Folic Acid (Vitamin M)FDA LinkGeneric 01/2022 - 01/2021
2	tenofovir alafenamideIBA 01/2021 - 01/2021
2	Hepatitis B Surface Antigens (HBsAg)FDA Link 09/2018 - 05/2018
1	MicronutrientsIBA 01/2022
1	Anti-Bacterial Agents (Antibiotics)IBA 08/2021
1	FumaratesIBA 01/2021
1	Tetanus Toxoid (Vaccine, Tetanus)FDA Link 01/2020
1	Antihypertensive Agents (Antihypertensives)IBA 01/2020
1	Nucleic AcidsIBA 11/2019
1	HIV AntibodiesIBA 11/2019
1	AntibodiesIBA 11/2019
1	ReaginsIBA 01/2019
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 05/2018
1	Biomarkers (Surrogate Marker)IBA 05/2018
1	E-SelectinIBA 05/2018
1	Interleukin-6 (Interleukin 6)IBA 05/2018
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 05/2018
1	RotaTeqIBA 01/2017
1	HDL CholesterolIBA 01/2017
1	CholesterolIBA 01/2017
1	CC ChemokinesIBA 06/2016
1	CXCR4 Receptors (CXCR4 Receptor)IBA 06/2016
1	Reverse Transcriptase InhibitorsIBA 01/2016
1	Vitamin D FDA LinkGeneric 11/2014
1	CreatinineIBA 05/2014
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 04/2013
1	Tyrosine (L-Tyrosine)FDA Link 04/2013
1	Anesthetics (Anesthetic Agents)IBA 02/2013
1	Local AnestheticsIBA 02/2013
1	Prilocaine Drug Combination Lidocaine FDA LinkGeneric 02/2013
1	CytokinesIBA 07/2012
1	abacavir (Ziagen)FDA Link 07/2012
1	Human immunodeficiency virus 1 p16 proteaseIBA 02/2012
1	AntigensIBA 01/2012
1	Proteins (Proteins, Gene)FDA Link 01/2012

Therapy/Procedure

12	Therapeutics 11/2019 - 08/2005
9	Highly Active Antiretroviral Therapy (HAART) 07/2013 - 06/2006
6	Art Therapy 01/2022 - 02/2012
3	Male Circumcision 01/2019 - 02/2013
1	Cesarean Section (Caesarean Section) 04/2022
1	Time-to-Treatment 01/2019
1	Traditional Medicine (Folk Remedies) 01/2016
1	Feeding Methods 01/2013